AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2012
Nov 5, 2012
31802_dirs_2012-11-05_b6f20390-ac95-4f79-acf0-3edcdac33c52.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-11-01
Reporting Person: Wade M. Andrew (Vice President, Finance)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5820 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $11.65 | 2017-12-05 | Common Stock (2000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $1.50 | 2019-02-10 | Common Stock (1000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $11.20 | 2021-02-09 | Common Stock (1000) | Direct | |
| Non-Qualified Stock Option (right to buy) | $6.27 | 2022-10-25 | Common Stock (35000) | Direct |
Footnotes
F1: Includes 4,500 shares of unvested restricted stock awarded under the AtriCure, Inc. 2005 Equity Incentive Plan.
F2: The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3